Compassionate Use Trial for Unresectable Melanoma With Ipilimumab

NCT00495066 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Melanoma

Interventions

DRUG: Ipilimumab

Sponsor

Bristol-Myers Squibb